Evaluating the Ferroptosis Potential and Mechanistic Variability of the Ferronucleoside TUC1 in the MIAPaCa2 Cell Line

dc.contributor.advisorHodges, Nikolas
dc.contributor.authorAlzahrani, Asma
dc.date.accessioned2024-03-05T07:42:38Z
dc.date.available2024-03-05T07:42:38Z
dc.date.issued2023-12-04
dc.description.abstractAddressing the therapeutic challenges of pancreatic ductal adenocarcinoma (PDAC), known for its rapid resistance to treatments like gemcitabine, we examined the capabilities of ferronucleoside 1-(S,Rp) TUC1. Notably, TUC1 demonstrated compelling efficacy against the gemcitabine-resistant MIAPaCa2 cells, closely matching cisplatin. Using MTT assays and accounting for variables like cell confluency and treatment duration, we assessed TUC1's cytotoxic impact. While the outcomes were on par with cisplatin, they varied across experimental conditions. Interestingly, based on cell confluency, we identified apoptosis as the primary cell death pathway, a departure from the initially hypothesized ferroptosis. This study highlights TUC1's complex mechanisms, underlining the need for more comprehensive research to further understand its effects.
dc.format.extent51
dc.identifier.citationHarvard
dc.identifier.urihttps://hdl.handle.net/20.500.14154/71572
dc.language.isoen
dc.publisherUniversity of Birmingham
dc.subjectOxidative stress
dc.subjectER stress
dc.subjectNucleoside analogues
dc.titleEvaluating the Ferroptosis Potential and Mechanistic Variability of the Ferronucleoside TUC1 in the MIAPaCa2 Cell Line
dc.typeThesis
sdl.degree.departmentBiosciences
sdl.degree.disciplineToxicology
sdl.degree.grantorUniversity of Birmingham
sdl.degree.nameMaster of Science

Files

Copyright owned by the Saudi Digital Library © 2024